Trademark: 97489332
Word
TACIT THERAPEUTICS
Status Date
Thursday, May 2, 2024
Filing Date
Tuesday, July 5, 2022
Published for Opposition
Tuesday, June 4, 2024
5 RNA editing gene therapeutics being pharmaceutical preparations for editing RNA for the treatment of inherited genetic diseases; RNA editing gene therapeutics being pharmaceutical preparations for editing RNA to treat inherited genetic diseases; RNA editing gene therapeutics being pharmaceutical preparations for editing RNA to treat inherited human genetic diseases; RNA-based gene therapies being pharmaceutical preparations for treatment of muscular dystrophies; RNA-based gene therapies being pharmaceutical preparations for the treatment of inherited neurological diseases; RNA-based gene therapies being pharmaceutical preparations for treatment of inherited retinal dystrophies; RNA-based gene therapies being pharmaceutical preparations for treatment of cancer; RNA-based gene therapies being pharmaceutical preparations for treatment of genetic liver diseases; RNA-based gene therapies being pharmaceutical preparations for treatment of inherited blood disorders
Jul 8, 2022
New Application Entered
Jul 8, 2022
New Application Office Supplied Data Entered
Apr 19, 2023
Assigned To Examiner
Apr 21, 2023
Non-Final Action Written
Apr 21, 2023
Non-Final Action E-Mailed
Apr 21, 2023
Notification Of Non-Final Action E-Mailed
Aug 9, 2023
Abandonment - Failure To Respond Or Late Response
Aug 9, 2023
Abandonment Notice Mailed - Failure To Respond
Aug 9, 2023
Abandonment Notice E-Mailed - Failure To Respond
Sep 20, 2023
Automatic Update Of Assignment Of Ownership
Sep 22, 2023
Teas Change Of Owner Address Received
Sep 22, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 22, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 22, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 22, 2023
Teas Change Of Correspondence Received
Sep 26, 2023
Teas Response To Office Action Received
Sep 26, 2023
Teas Petition To Revive Received
Sep 26, 2023
Petition To Revive-Granted
Sep 26, 2023
Notice Of Revival - E-Mailed
Sep 26, 2023
Notice Of Revival - E-Mailed
Feb 16, 2024
Assigned To Lie
Feb 16, 2024
Correspondence Received In Law Office
Feb 16, 2024
Teas/Email Correspondence Entered
May 2, 2024
Examiners Amendment -Written
May 2, 2024
Examiners Amendment E-Mailed
May 2, 2024
Notification Of Examiners Amendment E-Mailed
May 2, 2024
Examiner's Amendment Entered
May 2, 2024
Approved For Pub - Principal Register
Trademark Alertz updated from USPTO on 2030-01-24
